🌎 Headlines and Analysts’ Ratings for 12/28/2020

admin

Ratings changes for Xilinx, Applied Materials, Arcadia Biosciences, Intel, Paychex, Diamondback Energy, Kinnate Biopharma and more…Add MarketBeat to your address book or safe-sender list to make sure that your newsletter gets delivered to your inbox every time.Click here to learn how .Unsubscribe .VIEW MY PORTFOLIO December 28th, 2020 MarketBeat All Access New Years’ Sale –…

Ratings changes for Xilinx, Applied Materials, Arcadia Biosciences, Intel, Paychex, Diamondback Energy, Kinnate Biopharma and more…Add MarketBeat to your address book or safe-sender list to make sure that your newsletter gets delivered to your inbox every time.Click here to learn how .Unsubscribe .VIEW MY PORTFOLIO December 28th, 2020 MarketBeat All Access New Years’ Sale – Save $200.00 strong> Save $200.00 on Your MarketBeat All Access Subscription
MarketBeat All Access is our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools (My MarketBeat), MarketBeat’s full suite of research tools and stock screeners, a real-time news feed, email, and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more.You’ll also get access to our full database of more than 1,000,000 analyst recommendations, our proprietary broker performance and accuracy ratings, and a number of other exclusive benefits.
Why Upgrade to MarketBeat All Access?
– Early Delivery of MarketBeat Daily Premium (our daily newsletter)
– Access to our full database of 1 million analyst ratings
– SMS and email breaking news alerts for your stocks
– Live news feed of headlines, ratings, earnings, dividends, insider trades, and more.
– Portfolio monitoring tools (My MarketBeat)
– The MarketBeat Idea Engine
– Advanced research tools and screeners
– Brokerage performance rankings
– Priority delivery of your daily newsletter
– Premium customer support
– Extended Excel/CSV data export tools
– Additional premium reports
Save $200.00 on Your MarketBeat All Access Subscription Here
Today’s Top Stories Keep a Close Watch on a Declining Alibaba (NYSE:BABA) AT&T (NYSE:T) Takes a Hit on “Wonder Woman 1984” Returns Hidden Income ‘hack’ (ad) Apple (NASDAQ:AAPL) Scores Two More Bulls 3 Stocks that Doubled in 2020…and May Just be Getting Started 7 Stocks It May Be Time To Take Profits On DISH Network (NASDAQ: DISH) Stock is a Bargain Buy Here Time to Sell the News on Moderna (NASDAQ: MRNA) Stock Market Creates Buying Opportunity in Company Set to Revolutionize Marijuana (ad) The Analysts Are Driving The Semiconductors Higher Does Crocs (NASDAQ: CROX) Have More Upside? 7 Outdoor Recreation Stocks For Growth And Dividends Quick Links My MarketBeat Account Settings Analyst Ratings Company Profiles Dividend Declarations Earnings Announcements Headlines Insider Trades Insider Buying Stocks Insider Selling Stocks Buying Tesla Stock? Wait Until You See This…

(ad) With most investors focused on big tech, a frenzy is quietly erupting in one tiny sector, with gains like 500% in two months and 104% in a single day.
Click Here…
Your Watchlist
You have not added any stocks to your watchlist.
Click here to add stocks to your watchlist .
Analysts’ Upgrades AltaGas ( OTCMKTS:ATGFF ) was upgraded by analysts at Industrial Alliance Securities from a “buy” rating to a “strong-buy” rating.The current price is $14.60.Read More .Shawcor ( OTCMKTS:SAWLF ) was upgraded by analysts at Industrial Alliance Securities from a “hold” rating to a “buy” rating.The current price is $2.91.Read More .View today’s most recent analysts’ upgrades at MarketBeat.com
Bigger than the Internet? (ad) This breakthrough could be bigger than social media…
Bigger than Amazon…
In fact, it could be bigger than the Internet itself!
This groundbreaking technology could change everything…
Click now for the shocking details (before it’s too late).
Analysts’ Downgrades Aprea Therapeutics ( NASDAQ:APRE ) was downgraded by analysts at Robert W.Baird from an “outperform” rating to a “neutral” rating.The current price is $5.93.

Read More .CNS Pharmaceuticals ( NASDAQ:CNSP ) was downgraded by analysts at LADENBURG THALM/SH SH from a “buy” rating to a “neutral” rating.The current price is $1.75.

Read More .Ocular Therapeutix ( NASDAQ:OCUL ) was downgraded by analysts at HC Wainwright from a “buy” rating to a “neutral” rating.The current price is $22.01.Read More .PRGX Global ( NASDAQ:PRGX ) was downgraded by analysts at B.

Riley from a “buy” rating to a “neutral” rating.The current price is $7.62.Read More .PRGX Global ( NASDAQ:PRGX ) was downgraded by analysts at Barrington Research from an “outperform” rating to a “market perform” rating.The current price is $7.62.Read More .Suntory Beverage & Food ( OTCMKTS:STBFY ) was downgraded by analysts at Mizuho from a “buy” rating to a “neutral” rating.The current price is $18.00.Read More .

View today’s most recent analysts’ downgrades at MarketBeat.com
Free 30-Day Access To Expert Trading System (ad) Our friends at GorillaTrades are offering all readers the opportunity to get Free 30-day access to their Stock Picks, Options Picks, and Newsletters.

There is NO credit card required to sign up, all you need is your name and email address to try the Gorilla’s risk-averse trading system for the next 30 days.Get the edge you’ve been looking for, and try it today for free!
Click Here For Instant Access To Explosive Stock & Options Picks
Analysts’ New Coverage Amesite ( NASDAQ:AMST ) is now covered by analysts at Benchmark Co..They set a “buy” rating and a $7.00 price target on the stock.This represents a 40.0% upside from the current price of $5.00.Read More .Amicus Therapeutics ( NASDAQ:FOLD ) is now covered by analysts at Cantor Fitzgerald.They set an “overweight” rating and a $30.00 price target on the stock.This represents a 24.8% upside from the current price of $24.03.Read More .

Kinnate Biopharma ( NASDAQ:KNTE ) is now covered by analysts at Wedbush.They set an “outperform” rating and a $48.00 price target on the stock.This represents a 20.4% upside from the current price of $39.88.Read More .

Kinnate Biopharma ( NASDAQ:KNTE ) is now covered by analysts at Piper Sandler.

They set an “overweight” rating and a $60.00 price target on the stock.This represents a 50.5% upside from the current price of $39.88.Read More .Kinnate Biopharma ( NASDAQ:KNTE ) is now covered by analysts at The Goldman Sachs Group, Inc..They set a “buy” rating and a $48.00 price target on the stock.This represents a 20.4% upside from the current price of $39.88.Read More .Kinnate Biopharma ( NASDAQ:KNTE ) is now covered by analysts at SVB Leerink LLC.

They set an “outperform” rating and a $52.00 price target on the stock.This represents a 30.4% upside from the current price of $39.88.Read More .PAE ( NYSE:PAE ) is now covered by analysts at Morgan Stanley.They set an “overweight” rating and a $11.00 price target on the stock.This represents a 16.6% upside from the current price of $9.43.Read More .PAE ( NASDAQ:PAE ) is now covered by analysts at Morgan Stanley.

They set an “overweight” rating and a $11.00 price target on the stock.This represents a 16.6% upside from the current price of $9.43.

Read More .

The RMR Group ( NASDAQ:RMR ) is now covered by analysts at BTIG Research.They set a “buy” rating and a $45.00 price target on the stock.This represents a 13.0% upside from the current price of $39.84.Read More .VerifyMe ( OTCMKTS:VRME ) is now covered by analysts at Maxim Group.They set a “buy” rating on the stock.The current price is $3.73.Read More .

VerifyMe ( NASDAQ:VRME ) is now covered by analysts at Maxim Group.They set a “buy” rating on the stock.The current price is $4.01.Read More .View today’s most recent analysts’ new coverage at MarketBeat.com
More Calendars from MarketBeat U.S.Analyst Ratings , Canadian Analyst Ratings , U.K.Analyst Ratings , Corporate Buybacks , Cryptocurrencies , Dividend Declarations , Earnings Announcements , Earnings Conference Calls , Economic Reports , Gap Up/Down Stocks , Insider Trades , Initial Public Offerings (IPOs) , Most Active Stocks , Percentage Gainers/Decliners , Sector Performance , Short Interest , Stock Splits , Unusual Options Volume & Unusual Trading Volume .
Upgrade Your Subscription Upgrade to MarketBeat Daily Premium and receive your premium edition of MarketBeat Daily at 9:00 AM ET.UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat’s free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research.

MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!).If you have questions about your subscription, feel free to contact us via email at [email protected] or leave us a voice mail at (844) 978-6257.

If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
Β© 2006-2020 American Consumer News, LLC dba MarketBeat.326 E 8th St #105, Sioux Falls, SD 57103.United States..

Leave a Reply

Next Post

Serbia Legalizes Digital Assets Trading and Issuance

Dec 30, 2020 at 10:02 p.m.UTC Kosovo, Servia (Shutterstock) Serbia Legalizes Digital Assets Trading and Issuance In a reversal of previous policy, the Serbian government will now permit the issuance and trading of digital assets and related services under a law that went into effect Dec.29. The draft law was announced in October and local…

Subscribe US Now